ARNA Panacea is a blockchain-based ecosystem catered towards the medical research community. Read our review of ARNA Panacea and ARNA Genomics – the company behind the platform – today.
What is ARNA Genomics?
ARNA, or ARNA Genomics, is a blockchain technology that aims to offer high-precision tests for the early detection of breast cancer to a global market.
ARNA Genomics describes itself as an “innovative biotechnological company engaged in R&D and launching on market methods of oncological diseases early detection using blockchain-ecosystem ARNA Panacea.” And no, the website isn’t worded in perfect English.
ARNA Breast Cancer is one of the company’s products. It’s the first test developed for the early detection of breast cancer with a high level of precision.
ARNA Panacea, meanwhile, is a blockchain solution that provides all interested participants in the cancer diagnosis market with a new way of accessing and interacting with medical research data. Through the use of ARNA tokens, token holders can access services and medical research data storage systems that can be used for medical purposes, or to raise funds and introduce new research.
To be clear, ARNA Genomics is the company, and ARNA Panacea is the blockchain platform made by that company. ARNA Genomics has also developed a breast cancer test designed for the early detection of breast cancer.
How Does ARNA Panacea Work?
ARNA Panacea is a blockchain ecosystem built for medical studies and scientific research. The data storage system of the blockchain is used to collect evidence. That evidence will be used by regulators when assessing new drugs and treatments – say, when ARNA Genomics tries to introduce its early breast cancer detection test to the US market in the future.
Obviously, there’s a lot going on with ARNA. Here are some of the proposed uses for ARNA and the ARNA Panacea technology, as well as features of the platform:
Proof of Research: Any data stored in the ARNA Panacea public blockchain can provide the basis of evidence. It’s an immutable type of “proof of research” source.
Protected Research: ARNA will give users the ability to conduct scientific research in a secure format using encrypted keys on the blockchain.
Big Data: ARNA provides global access to the accumulated array of information through an open API interface. That API also has features that allow users to analyze available data.
Ecosystem: ARNA’s ecosystem consists of a single blockchain platform for collecting, storing, and analyzing information methods – say for the diagnosis and treatment of cancer.
Smart Blockchain: ARNA claims to have a “smart” blockchain because it can connect an AI to search for patterns, allowing the development of new methods of cancer treatment.
ARNA Tokens: ARNA tokens are designed to be used by patients, researchers, regulators, CROs, pharmaceutical companies, clinics, etc.
Who’s Behind ARNA?
ARNA is led by Egor Melnikov (Founder and CEO). Other key members of the team include George Nikitan (COO, Co-Founder, and Blockchain Platform Ideologist).
ARNA Genomics was founded in 2013. They conducted their first seed round of funding in 2014, and used that money to create the “ARNA Thermometr”, a test for the present of oncological diseases.
In 2015, ARNA Genomics developed ARNA Breast Cancer, a highly-precise test for early breast cancer detection. In 2016, they created a similar test for colon cancer.
In 2018, ARNA Genomics aims to open an office and laboratory in the United States while also launching the beta version of its ARNA Panacea platform.
The ARNA Token Sale
The ARNA Genomics token sale is scheduled for November 19 (at 6am PST) to December 3, 2017.
There will be a hard cap of $40 million USD. A total of 500 million ARNA tokens (listed under the symbol ARNA) will be sold at a fixed price of $0.80 per token. There’s a total supply of 1 billion ARNA tokens.
These tokens will be used to access the blockchain ecosystem of ARNA Panacea, including its data storage system. They’ll also be used to simulate the ecosystem’s growth and stability, to attract demand for medical data, and reward the addition of research data.
ARNA Genomics is developing a blockchain technology called ARNA Panacea. That blockchain features a data storage system and ecosystem catered towards the world of medical research. Researchers are incentivized to share data with the platform, while regulators can view data as evidence that a particular trial or test was successful.
ARNA Genomics, prior to creating this blockchain platform, has been heavily involved with creating early detection tests for cancer – including breast cancer tests. ARNA Panacea is designed to feature research from its early cancer detection tests – as well as the tests created by medical research companies worldwide.
The ARNA token sale is taking place from November 19 to December 3. You can learn more about ARNA online today at ARNAGenomics.com.